SCM
YARW

Superstring Capital Management’s Yarrow Bioscience YARW Stock Holding History

Superstring Capital Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.9K Buy
+1,225
New +$39.7K 0.03% 32

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Superstring Capital Management's YARW Position: Q2 2026 in Review

Superstring Capital Management opened a new position in Yarrow Bioscience (YARW) in Q2 2026: 1,225 shares worth $39.9K. The stake represents 0.03% of the portfolio and ranks #32 among its holdings.

40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Superstring Capital Management held 1,225 shares of Yarrow Bioscience worth $39.9K as of Q2 2026.
  • Yarrow Bioscience was a new Superstring Capital Management position in Q2 2026.
  • Yarrow Bioscience made up 0.03% of Superstring Capital Management's portfolio in Q2 2026, its #32 holding.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Superstring Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.